Floatz logo

Pimozide

Psychosis

Fundación Pública Andaluza para la gestión de la Investigación en SevillaSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
81/ 100

Competitive context

37 Active assets in the Psychosis cohort.

View all 50

Same molecule, other indications

Pimozide is also rated in:

schizoaffective disorderDormant
BB
Indicative ·
68 / 100
View asset →
schizophreniaDormant
BB
Indicative ·
64 / 100
View asset →
physiological malfunction arising from mental factorDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →